logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Hematopoietic Growth Factors In Oncology Basic Science And Clinical Therapeutics Cancer Drug Discovery And Development 1st Edition George Morstyn

  • SKU: BELL-1761046
Hematopoietic Growth Factors In Oncology Basic Science And Clinical Therapeutics Cancer Drug Discovery And Development 1st Edition George Morstyn
$ 31.00 $ 45.00 (-31%)

4.3

28 reviews

Hematopoietic Growth Factors In Oncology Basic Science And Clinical Therapeutics Cancer Drug Discovery And Development 1st Edition George Morstyn instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 7.49 MB
Pages: 488
Author: George Morstyn, MaryAnn Foote, Graham J. Lieschke
ISBN: 9781588293022, 1588293025
Language: English
Year: 2004
Edition: 1

Product desciption

Hematopoietic Growth Factors In Oncology Basic Science And Clinical Therapeutics Cancer Drug Discovery And Development 1st Edition George Morstyn by George Morstyn, Maryann Foote, Graham J. Lieschke 9781588293022, 1588293025 instant download after payment.

Leading oncologists, hematologists, and nephrologists comprehensively review the role of HGFs in clinical practice, explain the molecular basis of their effects, and consider potential future developments. The authors focus on the use of HGFs in oncology, describing their cutting-edge application to patients with lung cancer, Hodgkin's and nonhodgkin's lymphoma, breast cancer, chronic lymphocytic leukemia, AIDS-related malignancies, myelodysplastic syndromes, and aplastic anemias. Among the HGFs described are granulocyte colony-stimulating factor, erythropoietc factors, thrombopoietic factors, and stem cell factor and its receptor, C-kit. To complete their survey, the contributors also consider the safety and economic implications of HGFs and the future potential for HGF antagonists in oncology.

Related Products